{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:20:23Z","timestamp":1777634423416,"version":"3.51.4"},"reference-count":39,"publisher":"Oceanside Publications Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"Background:<\/jats:bold> Allergic rhinitis (AR) is traditionally subdivided into seasonal AR (SAR) and perennial AR (PAR) according to the type of allergen and the occurrence of symptoms during the year. There are currently no reports on the comparison of trait profiles for SAR and PAR\n during the allergen exposure. Purpose:<\/jats:bold> The purpose of this study was to analyze the clinical characteristics of SAR and PAR during respective allergen exposure periods to provide valuable information for the development of treatment strategies. Methods:<\/jats:bold>\n This study was performed between August 1, 2021, and January 31, 2022, in the Department of Allergy, Beijing Tongren Hospital. We continuously included diagnosed SAR and PAR outpatients who volunteered to participate in the survey. A questionnaire with regard to medical history, severity\n of symptoms, and diagnosis and treatment status was collected. Results:<\/jats:bold> A total of 296 patients with SAR and 448 with PAR were finally recruited. Patients with SAR had more severe rhinorrhea compared with patients with PAR (p\u2009<\u20090.001), whereas there was\n no statistically significant difference in the severity of itching, sneezing, and congestion between the two entities (p\u2009\u2265 0.05). Both the gritty and watery eyes of patients with SAR were noticeably more severe than those of patients with PAR (PTotal Ocular Symptom Score<\/jats:sub>\n [PTOSS<\/jats:sub>] < 0.001). AR symptom severity is mainly associated with the comorbid allergic conjunctivitis (odds ratio 1.94 [95% confidence interval, 1.21\u20103.09]). SAR patients and PAR patients show no statistically significant differences in terms of their frequency of visits,\n annual expenditure, and choice of medication treatment for AR (p > 0.05). The overall control under standard medication of both patients with PAR and those with SAR is not ideal, especially in SAR. Conclusion:<\/jats:bold> The current cross-sectional study demonstrated that the patients\n with SAR exhibited more severe overall clinical symptoms than those with PAR, especially nasal rhinorrhea and gritty and watery eyes. Both of the two disease entities have poor control under standardized medication treatment, especially in SAR. Further multicenter longitudinal studies that\n involve larger and more diverse populations should be conducted to provide a more accurate and comprehensive understanding of the condition.<\/jats:p>","DOI":"10.2500\/aap.2024.45.240009","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T04:50:02Z","timestamp":1715921402000},"page":"173-179","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure"],"prefix":"10.2500","volume":"45","author":[{"given":"Kunpeng","family":"Wang","sequence":"first","affiliation":[{"name":"From the Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianqi","family":"Wan","sequence":"additional","affiliation":[{"name":"From the Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyun","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Laboratory of Allergic Diseases and Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengshuo","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines\u20132016 revision","volume":"140","author":"Bro\u017cek","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1398-9995.2000.00526.x","article-title":"Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.","volume":"55","author":"van Cauwenberge","year":"2000","journal-title":"Allergy"},{"key":"B3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13223-021-00591-w","article-title":"Comparative analysis of chronic rhinitis patient profiles during autumn pollen season between grassland and non-grassland cities in North China","volume":"17","author":"Xu","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/all.13388","article-title":"Prevalence of pollen-induced allergic rhinitis with high pollen exposure in grasslands of northern China","volume":"73","author":"Wang","year":"2018","journal-title":"Allergy"},{"key":"B5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaci.2016.03.025","article-title":"MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis","volume":"138","author":"Bousquet","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13223-015-0093-x","article-title":"Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis","volume":"11","author":"Konig","year":"2015","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1398-9995.2005.00602.x","article-title":"Seasonal and perennial allergic rhinitis: is this classification adherent to real life?","volume":"60","author":"Ciprandi","year":"2005","journal-title":"Allergy"},{"key":"B8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/00016489.2012.656764","article-title":"Olfactory dysfunction in seasonal and perennial allergic rhinitis","volume":"132","author":"Becker","year":"2012","journal-title":"Acta Otolaryngol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1524-4733.2003.64231.x","article-title":"Seasonal versus perennial allergic rhinitis: drug and medical resource use patterns","volume":"6","author":"Crown","year":"2003","journal-title":"Value Health"},{"key":"B10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2500\/aap.2016.37.3984","article-title":"Health care resource use and associated costs among patients with seasonal versus perennial allergic rhinitis","volume":"37","author":"Lang","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"B11","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/all.14218","article-title":"Artemisia annua\u2013sublingual immunotherapy for seasonal allergic rhinitis: a randomized controlled trial","volume":"75","author":"Lou","year":"2020","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jaci.2012.04.034","article-title":"Nonlinear short-term effects of airborne Poaceae levels on hay fever symptoms","volume":"130","author":"Caillaud","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4168\/aair.2018.10.4.300","article-title":"Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis","volume":"10","author":"Cheng","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"B14","doi-asserted-by":"crossref","first-page":"e12094","DOI":"10.1002\/clt2.12094","article-title":"Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis","volume":"12","author":"Zhang","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"B15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1398-9995.2006.01276.x","article-title":"Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"},{"key":"B16","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaci.2009.02.033","article-title":"Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis","volume":"123","author":"Bousquet","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/all.12219","article-title":"Depigmented-polymerized mixed grass\/birch pollen extract immunotherapy is effective in polysensitized patients","volume":"68","author":"Pfaar","year":"2013","journal-title":"Allergy"},{"key":"B19","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.jaip.2018.01.031","article-title":"Onset of action of the fixed combination intranasal azelastine\u2013fluticasone propionate in an allergen exposure chamber","volume":"6","author":"Bousquet","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B20","doi-asserted-by":"crossref","first-page":"1073788","DOI":"10.3389\/fimmu.2023.1073788","article-title":"Effect of immunostimulation with bacterial lysate on the clinical course of allergic rhinitis and the level of gammadeltaT, iNKT and cytotoxic T cells in children sensitized to grass pollen allergens: a randomized controlled trial","volume":"14","author":"Janeczek","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/alr.23098","article-title":"Rhinitis symptom in patients with self-reported allergic rhinitis is influenced by sensitization pattern: a cross-sectional study of China","volume":"13","author":"Wu","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.otohns.2007.10.027","article-title":"Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis","volume":"138","author":"Naclerio","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B23","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/alr.22166","article-title":"Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis","volume":"8","author":"Seresirikachorn","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"B24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1081-1206(10)61225-2","article-title":"Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis","volume":"95","author":"Lange","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1081-1206(10)60452-8","article-title":"Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis","volume":"100","author":"Anolik","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/alr.21382","article-title":"Subcutaneous immunotherapy","volume":"4","author":"Roche","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.anai.2011.07.014","article-title":"Nasal carbon dioxide for the symptomatic treatment of perennial allergic rhinitis","volume":"107","author":"Casale","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaip.2017.05.028","article-title":"Nasal carbon dioxide used as needed in the symptomatic treatment of seasonal allergic rhinitis","volume":"6","author":"Casale","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1398-9995.2008.01846.x","article-title":"Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitis","volume":"64","author":"Humbert","year":"2009","journal-title":"Allergy"},{"key":"B30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jaip.2014.02.001","article-title":"Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials","volume":"2","author":"Tsabouri","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.anai.2020.05.026","article-title":"Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis","volume":"125","author":"Busse","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B32","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1111\/all.14308","article-title":"Past, present, and future of anti-IgE biologics","volume":"75","author":"Guntern","year":"2020","journal-title":"Allergy"},{"key":"B33","first-page":"501","article-title":"Omalizumab for the treatment of allergic rhinitis: a systematic review and meta-analysis","volume":"59","author":"Tsabouri","year":"2021","journal-title":"Rhinology"},{"key":"B34","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1001\/jama.286.23.2956","article-title":"Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial","volume":"286","author":"Casale","year":"2001","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11882-010-0087-1","article-title":"Allergic conjunctivitis and the impact of allergic rhinitis","volume":"10","author":"Bielory","year":"2010","journal-title":"Curr Allergy Asthma Rep"},{"key":"B36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41533-018-0071-0","article-title":"Tell me about your hay fever: a qualitative investigation of allergic rhinitis management from the perspective of the patient","volume":"28","author":"Cvetkovski","year":"2018","journal-title":"NPJ Prim Care Respir Med"},{"key":"B37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/all.13098","article-title":"Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control","volume":"72","author":"Belhassen","year":"2017","journal-title":"Allergy"},{"key":"B38","doi-asserted-by":"crossref","first-page":"e12148","DOI":"10.1002\/clt2.12148","article-title":"Direct and indirect costs of allergic and non-allergic rhinitis to adults in Beijing, China","volume":"12","author":"Li","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"B39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/all.13099","article-title":"Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study","volume":"72","author":"Colas","year":"2017","journal-title":"Allergy"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2024\/00000045\/00000003\/art00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T04:36:34Z","timestamp":1726202194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2024.45.240009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5,1]]}},"alternative-id":["1088-5412(20240501)45:3L.173;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2024.45.240009","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}